Catherine E. Loveland-Jones, MD, MS, FACS

4.94 out of 5 (157 ratings, 42 reviews)
Ratings and Reviews

Departments

Cooper University Health Care Titles

  • Co-Director, Janet Knowles Breast Cancer Center
  • Head, Division of Breast Surgery

Program Director, Breast Surgical Oncology Fellowship

Cooper Medical School of Rowan University Titles

  • Associate Professor of Clinical Surgery

Board Certifications

  • American Board of Surgery (Surgery - General)

Professional Type

Cooper University Physician

NPI

1295996361

About Me

 

What inspired you to become a cancer specialist?

At each step of a patients journey with cancer, from diagnosis through treatment and recovery, there are tremendous opportunities to instill hope. It gives me great satisfaction to know that I am able to help patients through this difficult time.

What is your essential patient care philosophy?

To provide each patient with a surgeon who is both compassionate and clinically skilled.

What do you hope your patients say about you to their family and friends?

I would like them to say: My outcome was excellent! I felt like she truly cared for me.

What three words best describe you?

Hard-working, perfectionistic, and kind.

Office Locations

Camden, Egg Harbor Township, Voorhees
MD Anderson Cancer Center at Cooper - Voorhees

900 Centennial Boulevard
Building 1
Suite F
Voorhees , NJ 08043
Phone: 855.MDA.COOPER (855.632.2667)
Fax: 856.325.6645
Maps & Directions

Education & Training

Medical SchoolUniversity of Pennsylvania School of Medicine, Philadelphia, PA
ResidencyGeneral Surgery - Temple University Hospital, Philadelphia, PA
FellowshipSurgical Breast Oncology - University of Texas MD Anderson Cancer Center, Houston, TX

Special Interests

Breast cancer, benign breast disease, high risk management

Memberships

  • Association of Program Directors in Surgery
  • Society of Surgical Oncology
  • American Society of Breast Surgeons
  • Association of Women Surgeons
  • American College of Surgeons
  • Philadelphia Academy of Surgery

Awards and Honors

  • SJ Magazine "Top Docs" in Breast Surgery
    Physician Poll - 2020, 2022, 2023
    Patient Poll - 2022
  • SJ Magazine "Top Female Docs" in Breast Surgery
    Physician Poll - 2020, 2023
    Patient Poll - 2023
  • Golden Apple Award, Cooper Medical School of Rowan University - May 2020
  • Pink and Teal Hero, The Cooper Foundation - 2017
  • Corynne S. Uhl Award for Compassionate and Excellent Care in Breast Surgical Oncology, MD Anderson Cancer Center - 2015
  • SJ Magazine "Top Female Docs" - 2023, 2024

Publications

Rombeau JL, Goldberg AJ, Loveland-Jones CE. Surgical Mentoring: Building Tomorrows Leaders. Springer, New York NY, 2010.

Siderowf AD, Jaggi JL, Xie Sx, Loveland-Jones CE, Leng L, Hurtig HI, Colcher A, Stern MB, Chou KL, Liang GS, Maccarone H, Simuni T, Baltuch GH. Long-term effects of bilateral subthalamic nucleus stimulation on quality-of-life in advanced Parkinsons disease. Movement Disorders 2006; 21(6):746-53.

Liang GS, Chou KL, Baltuch GH, Jaggi JL, Loveland-Jones CE, Leng L, Maccarone H, Hurtig HI, Colcher A, Stern MB, Kleiner-Fisman G, Simuni T, Siderowf AD. Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinsons disease. Stereotactic and Functional Neurosurgery 2006; 84(5-6):221-7.

Loveland-Jones CE, Wang F, Bankhead RR, Reilly KJ. Squamous cell carcinoma of the nipple following radiation therapy for ductal carcinoma in situ: a case report. J Medical Case Reports 2010; 4:186.

Boden G, Salehi S, Cheung P, Homko C, Song W, Loveland-Jones CE, Jayarajan S. Comparison of in vivo effects of insulin on SREBP-1c and INSIG-1/2 in rat liver and human and rat adipose tissue. Obesity 2013; 21(6):1208-14.

Boden G, Cheung P, Salehi S, Homko C, Loveland-Jones CE, Jayarajan S, Stein TP, Barrero CA, Merali S. Insulin regulates the unfolded protein response (UPR) in human adipose tissue. Diabetes 2014; 63(3):912-22.

Loveland-Jones CE, Ruth K, Sigurdson ER, Egleston BL, Boraas M, Bleicher RJ. Breast conservation surgery in the Medicare patient: Will the American College of Surgeons Oncology Group Trial Z0011 change the pattern of care? Breast Cancer Research & Treatment 2014; 143(3):571-7.

Loveland-Jones CE, Jayarajan S, Fang J, Monroy A, Zhang A, Holt-Bright L, Choi ET. A new model of arteriovenous fistula to study hemodialysis access complications. Journal of Vascular Access 2014. Epub ahead of print.

Loveland-Jones CE, Lin H, Shen Y, Bedrosian I, Shaitelman S, Kuerer H, Woodward W, Ueno N, Valero V, Babiera G. Disparities in the Use of Postmastectomy Radiation Therapy for Inflammatory Breast Cancer. Int J Radiat Oncol Biol Phys 2016; 95(4):1218-25.

Loveland-Jones CE, Charles SP, VanZandt A, Santora TA, Pathak AS, Gaughan JP, Dubin WR, Goldberg AJ. A prospective randomized study of the efficacy of Turning Point, an inpatient violence intervention program. Accepted for publication by the Journal of Trauma, June 2016.

Gandhi S, Sudheendra P, Rafferty W, Loveland-Jones C. Case report and review of adolescent atypical ductal hyperplasia and juvenile fibroadenoma: How do we assess and manage future risk? Clin Breast Cancer. 2018; 18(5):e751-754.

Kuerer HM, Smith BD, Krishnamurthy S, Yang WT, Valero V, Shen Y, Lin H, Lucci A, Boughey JC, White RL, Diego EJ, Rauch GM, Moseley TW, Parra RF, Adrada BE, Leung JW, Sun SX, Teshome M, Miggins MV, Hunt KK, DeSnyder SM, Ehlers RA, Hwang RF, Colen JS, Arribas E, Samiian L, Lesnikoski A, Piotrowski M, Bedrosian I, Chong C, Refinetti AP, Huang M, Candelaria RP, Loveland-Jones C, Mitchell MP, Shaitelman SF. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicenter, single-arm, phase 2 trial. Lancet Oncol. 2022; published online Oct 25. PMID: 36306810.

Catherine Loveland-Jones, John Gaughan, Abigail Caudle, Brittany Murphy, Laila Samiian, Stephanie Byrum, Kristen Brill, Pauline Germaine, Xinmin Zhang, Kay Yoon-Flannery, Teralyn Carter, Adrian Lopez, Ryan Gruner, Michele Fantazzio, Henry Kuerer. Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registry. Eur J Surg Oncol 2024 Mar 3;50(4):108245. doi: 10.1016/j.ejso.2024.108245.

Ratings and Reviews

Ratings and reviews come from patient responses to health care provider-related questions on the Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) Patient Experience Survey that Cooper sends to patients after outpatient office visits.  Learn more about our survey and how ratings are calculated >>

Overall Rating

4.94 out of 5 (157 ratings, 42 reviews)
Aug 12, 2023
My experiences at this office was excellent everyone was kind considerate and show much respect.
Aug 12, 2023
Dr. loveland-jones and all the other professionals were wonderful. I felt very comfortable and repspected by the staff.
Jul 12, 2023
Everyone was polite and respectful. I was very comfortable.
Jun 12, 2023
I had the best experience possible given the circumstances of being told I have breast cancer.
Jun 12, 2023
Everyone was excellent. I left my previous provider for Dr. Loveland-Jones. She made me feel secure and confident in her skills as a doctor.
Jun 12, 2023
Everyone involved professional - Respectful - Thoughtful.
May 12, 2023
Thorough and informative
May 12, 2023
My experience was excellent.
May 12, 2023
I had one of the best experiences ever with a doctor and assistants. This was my 1st visit with this doctor and office.
May 12, 2023
An excellent visit with Dr. Loveland Jones and staff